Targeted Delivery of Ubiquitin-Conjugated BH3 Peptide-Based Mcl-1 Inhibitors into Cancer Cells

[Image: see text] BH3 peptides are key mediators of apoptosis and have served as the lead structures for the development of anticancer therapeutics. Previously, we reported the application of a simple cysteine-based side chain cross-linking chemistry to NoxaBH3 peptides that led to the generation of...

Descripción completa

Detalles Bibliográficos
Autores principales: Muppidi, Avinash, Doi, Kenichiro, Edwardraja, Selvakumar, Pulavarti, Surya V. S. R. K., Szyperski, Thomas, Wang, Hong-Gang, Lin, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974624/
https://www.ncbi.nlm.nih.gov/pubmed/24410055
http://dx.doi.org/10.1021/bc4005574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974624/
https://www.ncbi.nlm.nih.gov/pubmed/24410055
http://dx.doi.org/10.1021/bc4005574

Ejemplares similares